Vimarsana
Biggest News Aggregation in the World

Page 12 - Nasdaq Coll News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Coll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Coll Today - Breaking & Trending Today

Research Analysts' Weekly Ratings Updates for Collegium Pharmaceutical (COLL) - Vimarsana News

Research Analysts' Weekly Ratings Updates for Collegium Pharmaceutical (COLL)

Collegium Pharmaceutical (NASDAQ: COLL) recently received a number of ratings updates from brokerages and research firms: 4/11/2022 – Collegium Pharmaceutical was downgraded by analysts at TheStreet from a “b-” rating to a “c+” rating. 4/6/2022 – Collegium Pharmaceutical had its price target raised by analysts at Needham & Company LLC from $34.00 to $36.00. They […]

$79.05 Million in Sales Expected for Collegium Pharmaceutical, Inc. (NASDAQ:COLL) This Quarter - Vimarsana News

$79.05 Million in Sales Expected for Collegium Pharmaceutical, Inc. (NASDAQ:COLL) This Quarter

Brokerages predict that Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) will report sales of $79.05 million for the current fiscal quarter, according to Zacks. Four analysts have made estimates for Collegium Pharmaceutical’s earnings. The highest sales estimate is $83.33 million and the lowest is $75.10 million. Collegium Pharmaceutical posted sales of $87.72 million in the […]

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Expected to Announce Earnings of $1.10 Per Share - Vimarsana News

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Expected to Announce Earnings of $1.10 Per Share

Wall Street analysts expect Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) to announce earnings of $1.10 per share for the current quarter, according to Zacks. Four analysts have issued estimates for Collegium Pharmaceutical’s earnings. The lowest EPS estimate is $0.92 and the highest is $1.21. Collegium Pharmaceutical posted earnings per share of $0.41 during the […]

Zacks: Analysts Anticipate Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Will Post Quarterly Sales of $83.53 Million - Vimarsana News

Zacks: Analysts Anticipate Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Will Post Quarterly Sales of $83.53 Million

Wall Street analysts predict that Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) will post $83.53 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Collegium Pharmaceutical’s earnings, with estimates ranging from $80.58 million to $86.48 million. Collegium Pharmaceutical posted sales of $87.72 million during the same […]